65,437 trials
Pulmonary Hypertension · Chronic Obstructive Pulmonary Disease (COPD)
Primary: Change in 6 Minute Walk Test — 7.00; 16.60; 16.00; 4.90 Meters walked in 6 minutes
Neuroendocrine Tumors
Primary: Objective Response Rate (ORR) — 1 Participants
Bladder Cancer
Primary: Number of Days Step Goal Completed — 4.5; 9 days
Anaemia · Haemodialysis
Primary: Haemoglobin Increase of Greater or Equal to 5g/l Following Receipt of Treatment — 53; 61 Participants
Episodic Migraine
Primary: Change From Baseline in Monthly Migraine Days at the Last Month (Month 3) of the Double-blind Treatment Period (DBTP) — -4.20; -4.79; -3.10 Migraine days/month — p=0.002
HIV Infections
Primary: Change in Short-term Virologic Response — -.11; -.15; -.16; -.16 log(10) copies/mL per day
Plaque Induced Gingivitis
Primary: Change From Baseline Gingivitis at Day 14 as Measured by Non-invasive Microimaging and Gingival Index. — 0.6; 0.15 units on a scale
Neoplasms
Primary: Change in Patient Experience From Baseline to Follow up — 90.1; 90.0; 92.8; 92.4 units on a scale — p=.025
Triage · Risk Stratification With Biomarker
Primary: All Cause Mortality — 1126; 1241 Participants
Chronic Rhinosinusitis · Aspirin Exacerbated Respiratory Disease · Asthma
Primary: Urinary Levels of Cys-Leukotrienes — 874.05; 771.99 pg/ml
Smoking Cessation · Smoking, Cigarette · Nicotine Dependence
Primary: Craving Levels in Response to Cue — 69.6; 66.3; 56.1; 74.4 score on a scale
Cognitive Control
Primary: Post vs. Pre Change in Mid-frontal Theta Oscillations for iTBS vs. cTBS Stimulation — -0.043; 0.017 microVolts (uV) at FCz EEG electrode
Opioid-use Disorder
Primary: Sublocade Induction — 10 Participants
Subclinical Hypothyroidism
Primary: TSH Area Under the Curve — 267.8; 266.2 μIU*min/mL
Laparoscopic Gastric Bypass · Obesity · Pain, Postoperative
Primary: Pain Measured Based on Pain Medication Used on a Scale of 0-10 — 1.3; 0.7 units on a scale